ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ITX Itaconix Plc

160.00
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Itaconix Plc LSE:ITX London Ordinary Share GB00BPK3YZ68 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 160.00 155.00 165.00 160.00 160.00 160.00 3,119 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chemicals & Chem Preps, Nec 5.6M -2.46M -0.1826 -8.76 21.58M
Itaconix Plc is listed in the Chemicals & Chem Preps sector of the London Stock Exchange with ticker ITX. The last closing price for Itaconix was 160p. Over the last year, Itaconix shares have traded in a share price range of 114.00p to 276.00p.

Itaconix currently has 13,486,122 shares in issue. The market capitalisation of Itaconix is £21.58 million. Itaconix has a price to earnings ratio (PE ratio) of -8.76.

Itaconix Share Discussion Threads

Showing 4001 to 4025 of 10675 messages
Chat Pages: Latest  163  162  161  160  159  158  157  156  155  154  153  152  Older
DateSubjectAuthorDiscuss
03/11/2020
07:23
Taken from her LinkedIn:AboutTwenty + years of product development and sales, applications and plant scale-up in the oleochemicals industry. Product formulation experience in hair care and skin care, cosmetics, OTC and Rx. Experience also incorporates manufacturing responsibilities in technology transfer (scale-up and production), as well as stability testing (physical, sensory) for prototype formulations to commercial products. Additional pharmaceutical excipient and delivery applications knowledge.Specialties: Strengths include business development, technical sales, account management, sales marketing, formulating new innovative products, managing laboratory teams and technical writing. Author or co-author of seven US patents, authored or co-authored five technical papers and three presentations at national or international symposiums.
parob
03/11/2020
07:22
Yes it looks a very good and logical appointment, she was at Glatfelter who have almost a billion dollar turnover in 'engineered materials... custom solutions found in food and beverage applications, personal hygiene products, building and industrial products, home care and more'
photon
03/11/2020
07:17
Extra pair of sales hands appointed as the company grows. Great move.
parob
02/11/2020
21:38
Not complaining , its why i invested as a engineer can see the merit also being conservative in future growth. When Directors produce future growth its more luck that they turn out to be true , in this case it could be 2 months to add a new company to sell or 1 or 2 years.
Frank answers in the question

ITX is on the brink of breaking a profit , that could be six months or 14 Months but in the end its skyward

Have faith or sell

thordon
02/11/2020
21:01
Straight from the hip.I prefer to hear it just how it is.
geraldus
02/11/2020
20:01
I think that showed in the Q&A. He was keen to share lots of interesting information but somehow made it all sound negative - I think because I am so used to stupidly positive spins by most companies that I have to try to see through. The Q&A was a 'warts and all' description of the situation (supply channels, competitors, timescales to new business) that potential investors have to look hard to find the positives in.
ewanwhose
02/11/2020
19:26
He also stated that he was no dab hand at dealing with shareholders or the price and was and always be a Chemical engineer.
thordon
02/11/2020
12:27
I agree. He also broke with recent stance and did not provide an update on revenue
the ghost who walks
02/11/2020
12:21
Yes frustrating and unreasonable. The interim figures were excellent with sales well up and good projections for 2021. The problem is not what was in the report (and interview) but what was missing. I think the market had been hoping for news of a fantastic contract with a major international company - Unilever or the likes. In fact John Shaw was fairly reserved and actually had no news to add to his previous interview. I was a bit disappointed, but this is going to take time. As I posted before when ITX was re-listed its marketcap was £53 million - it's now back to £8.7 million.
ivor hunch
02/11/2020
08:25
Below 2. Frustrating.
the ghost who walks
30/10/2020
12:21
New interview. John states they're looking to break even in 12-18 months time. hTTps://www.youtube.com/watch?v=--z2xuzRcicItaconix set to 'continue with progress made this year through to next year'2020-10-30 12:00:00Itaconix PLC's (LON:ITX) John Shaw talks to Proactive London about their first half of the year performance which saw the company's chemistries used more by major brands in everyday products.He says as revenues increase, they are 'really narrowing losses down' towards goals of reaching break even and beyond'.Shaw is expecting the next half to be stronger, and build upon the progress already made, which saw revenues in the six months to the end of June 2020 shoot up 80% to $1.1m from $604K in the first half of 2019.
parob
29/10/2020
19:31
Thanks wololol ; nice to be wrong and not picked that information up.
Anyway its good to know IP Group still invested ; was a long term holder of theirs but sold out to during the march crisis to protect other investments.

To me this company is not a Risk Company we all know the results in the end - Months to years this coming good.

thordon
29/10/2020
19:06
Looking at the Allenby Capital note from July 2020.The Conclusion states - " the sales pipeline potential is running at around $20m and longer term Itaconix has a 7 year revenue target of $79m with an adressable ingredient market of $705m." - which is about what JS stated yesterday.
geraldus
29/10/2020
17:36
Thordon. The Institutions that participated in the fund raise are locked in and can't sell for a year - its in the terms and conditions of the fundraise. In addition, ITX largest shareholders IP group, Guy Broadbent, ITX Directors actually added significantly more the fund raise and have never sold a penny so it's in safe/sticky hands.
wololol
29/10/2020
16:47
Gives me more chance to add to this stock , have a 5 year long term plan for itx.
This is really a share at present for the PI as can not see TR1 or TR2 buying in.
Also remember the fund raise which will drag the share down for Months till they sell out.

thordon
29/10/2020
15:41
I didn't expect to see ITX back on the losers board so soon, I guess the market is saying "show me the money", which of course being AiM seldom happens.
lefrene
29/10/2020
12:36
Bad Gateway,

I don't believe they can say when they will be profitable because it depends on launch time and sales traction in new and yet to launch lines they have been qualified in.

What did seem clear was the confidence that even what they have already been qualified in will ensure the success of the company going forwards.

You are correct though, timescales involved mean that current market direction makes this an easier one for the less patient to sell.

Personally, I am trying not to over trade. I cut a couple of stocks a few days back and hovered on the sell button with these yesterday - but I decided to stay put. I am sitting on a nice profit. It might erode in the short term.

G.

garth
29/10/2020
11:48
Definitely comes over as one of those guys who thinks if he does the business the share price will surely follow, which isn't always the case.

On the other hand, as far as I can see, he is doing the business, so I'm happy to be patient.

supernumerary
29/10/2020
11:42
Market cap back down to £8.5M. Potential acquisition target for one of the big players. This MCap would be small change for them.
parob
29/10/2020
11:38
Thought the presentation showed promise but sold due to the lack of clarity on when they'd become profitable. Couldn't see how that would go down well in todays market. Almost seemed he didn't care about such things which was a shame.
Will still keep an eye on RNS's/presentations for more guidance on that one going forward but will wait til thats addressed better before buying back.

bad gateway
28/10/2020
20:11
True,but was the same yesterday and more likely more to come.Reality kicking in.
geraldus
28/10/2020
19:52
Think your find that there was a bloodbath on today markets on the stock-exchange that did not help.
thordon
28/10/2020
17:52
Dropped back with the presentation,people expecting more maybe.
geraldus
28/10/2020
15:11
I just listened in to the call and overall found it good. I feel he was a bit more cautious in revenues and timing of those, there were some good questions on the 75mln the previously showed and he was cautious in this. I would say that was a marginal negative.Against that, I think they are very confident in near term prospects and road to profitability. He was more bullish here in my view.
the ghost who walks
28/10/2020
14:14
Well the market didn't seem to like the presentation 😂

I still need 10p here to break even having been in way too deep during the Revolymer debacle 😕

dexdringle
Chat Pages: Latest  163  162  161  160  159  158  157  156  155  154  153  152  Older

Your Recent History

Delayed Upgrade Clock